IntroductionAcute and chronic skin conditions affecting the appearance of visible skin are associated with both physical and psychological symptoms and lower quality of life.1,2 In individuals with skin of color,…
Read More
INTRODUCTIONAtopic dermatitis (AD) is one of the most common inflammatory skin disorders. It is present in both the very young and the very old and is a significant cause of…
Read More
INTRODUCTIONLong-term maintenance of clear skin is a primary treatment goal for most patients with psoriasis. Ineffective response or loss of response to systemic therapy necessitates a change in treatment. In…
Read More
INTRODUCTION1. IL-4 and IL-13 Blockade is Not Immunosuppressive Treating widespread, moderate-to-severe atopic dermatitis (AD) has classically been done with immunosuppressive medications, such as methotrexate, cyclosporine, or azathioprine. Dupilumab changed this…
Read More
INTRODUCTIONRosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves increased cutaneous density of Demodex folliculorum mites, which drive inflammation through activation…
Read More
INTRODUCTION Body-focused repetitive disorders (BFRBs) are psychocutaneous disorders that are underrecognized and undertreated. They are characterized by the performance of a specific body-focused repetitive behavior (eg, hair pulling, skin picking,…
Read More
INTRODUCTIONOnychomycosis represents the most common nail condition seen in clinical practice amongst adults, comprising 50% of all nail disorders seen in the ambulatory setting.1 Clinically, onychomycosis can present with yellow…
Read More
INTRODUCTIONAtopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children, with a…
Read More
INTRODUCTIONTherapeutic Challenge How can we ensure dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis? Solution We developed a mnemonic ENLIGHTEN to help healthcare…
Read More
introductionNemolizumab is a humanized monoclonal antibody directed against the interleukin (IL)-31 receptor alpha chain (IL-31RA) that blocks signaling from neuroimmune cytokine IL-31. While IL-31 was first thought to be primarily…
Read More
INTRODUCTIONPsoriasis is a significant health and economic burden. In the United States, the prevalence of psoriasis is estimated to be 7.4 million, which accounts for ~2.2% of the population, with…
Read More
INTRODUCTIONCutaneous warts are benign growths on the skin that can affect various parts of the body, most commonly the face, hands, and feet.1 Warts affect 10% of the population and…
Read More
